On Tuesday, Autolus Therapeutics plc ADR (NASDAQ: AUTL) opened lower -3.73% from the last session, before settling in for the closing price of $1.34. Price fluctuations for AUTL have ranged from $1.11 to $3.45 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 21.35%. Company’s average yearly earnings per share was noted -5.16% at the time writing. With a float of $240.33 million, this company’s outstanding shares have now reached $266.14 million.
Autolus Therapeutics plc ADR (AUTL) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Autolus Therapeutics plc ADR is 9.70%, while institutional ownership is 50.84%.
Autolus Therapeutics plc ADR (AUTL) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.09 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.24) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.42% during the next five years compared to 21.35% growth over the previous five years of trading.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Trading Performance Indicators
Check out the current performance indicators for Autolus Therapeutics plc ADR (AUTL). In the past quarter, the stock posted a quick ratio of 5.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Autolus Therapeutics plc ADR (AUTL)
The latest stats from [Autolus Therapeutics plc ADR, AUTL] show that its last 5-days average volume of 3.13 million was superior to 2.37 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 34.84%.
During the past 100 days, Autolus Therapeutics plc ADR’s (AUTL) raw stochastic average was set at 4.08%, which indicates a significant decrease from 15.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0999 in the past 14 days, which was lower than the 0.1194 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4980, while its 200-day Moving Average is $1.7713. Now, the first resistance to watch is $1.3133. This is followed by the second major resistance level at $1.3367. The third major resistance level sits at $1.3533. If the price goes on to break the first support level at $1.2733, it is likely to go to the next support level at $1.2567. Assuming the price breaks the second support level, the third support level stands at $1.2333.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Key Stats
There are currently 266,141K shares outstanding in the company with a market cap of 343.32 million. Presently, the company’s annual sales total 10,120 K according to its annual income of -220,660 K. Last quarter, the company’s sales amounted to 21,190 K and its income totaled -79,120 K.
